279 related articles for article (PubMed ID: 35060360)
1. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
[TBL] [Abstract][Full Text] [Related]
3. CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.
Irwin DJ; Xie SX; Coughlin D; Nevler N; Akhtar RS; McMillan CT; Lee EB; Wolk DA; Weintraub D; Chen-Plotkin A; Duda JE; Spindler M; Siderowf A; Hurtig HI; Shaw LM; Grossman M; Trojanowski JQ
Neurology; 2018 Mar; 90(12):e1038-e1046. PubMed ID: 29467305
[TBL] [Abstract][Full Text] [Related]
4. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
[TBL] [Abstract][Full Text] [Related]
7. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
[TBL] [Abstract][Full Text] [Related]
8. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
9. Tau pathology associates with in vivo cortical thinning in Lewy body disorders.
Spotorno N; Coughlin DG; Olm CA; Wolk D; Vaishnavi SN; Shaw LM; Dahodwala N; Morley JF; Duda JE; Deik AF; Spindler MA; Chen-Plotkin A; Lee EB; Trojanowski JQ; McMillan CT; Weintraub D; Grossman M; Irwin DJ
Ann Clin Transl Neurol; 2020 Dec; 7(12):2342-2355. PubMed ID: 33108692
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
[TBL] [Abstract][Full Text] [Related]
12. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
13. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
Ferman TJ; Aoki N; Crook JE; Murray ME; Graff-Radford NR; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford J; Pedraza O; Kantarci K; Boeve BF; Dickson DW
Alzheimers Dement; 2018 Mar; 14(3):330-339. PubMed ID: 29100980
[TBL] [Abstract][Full Text] [Related]
14. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
15. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
[TBL] [Abstract][Full Text] [Related]
16. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
17. The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics.
Noguchi-Shinohara M; Ono K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373401
[TBL] [Abstract][Full Text] [Related]
18. Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.
Paleologou KE; Kragh CL; Mann DM; Salem SA; Al-Shami R; Allsop D; Hassan AH; Jensen PH; El-Agnaf OM
Brain; 2009 Apr; 132(Pt 4):1093-101. PubMed ID: 19155272
[TBL] [Abstract][Full Text] [Related]
19. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
[TBL] [Abstract][Full Text] [Related]
20. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.
Irwin DJ; Hurtig HI
J Alzheimers Dis Parkinsonism; 2018; 8(4):. PubMed ID: 30473927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
